Pure Global
Disease/Condition
357 Clinical Trials
10+ Countries

Cardiovascular Disease Clinical Trials Database - Free Access to 357 Studies

Access comprehensive clinical trial information for Cardiovascular Disease through Pure Global AI's free database. This collection includes 357 clinical trials across multiple phases including N/A, Phase 1, Phase 3. Currently, 16 trials are actively recruiting participants.

Research for Cardiovascular Disease is being conducted in United States of America, United Kingdom, Canada and 7+ other countries. Leading sponsors include Penn State University and AstraZeneca. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Free Database
Powered by Pure Global AI
840K+ Global Trials
Updated Daily
By Phase
N/A
247
Phase 1
33
Phase 3
21
Phase 4
21
Phase 2
17
By Status
Completed
265
Unknown
28
Recruiting
16
Terminated
13
Not yet recruit...
13
Top Countries
United States of America129
United Kingdom38
Canada25
China13
France11
Top Sponsors
Penn State Univers...12
AstraZeneca11
National Heart, Lu...10
GlaxoSmithKline8
University of Read...7
Recent Trials
Latest clinical trials for Cardiovascular Disease
SLCTR_2022_016
Not Applicable
Recruiting

Randomized crossover controlled clinical trial to assess the comparative acute effects of saturated fat rich meal (coconut fat and butter) with unsaturated fat rich meal (sesame oil) on vascular reactivity, blood pressure, plasma lipids and markers of insulin resistance in healthy adult men.

Wayamba University Research Gr...Sri Lanka
PHRR200909-002920
Phase 3
Terminated

A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein (a) lowering with TQJ230 on major cardiovascular events in patients with established cardiovascular disease

Novartis Healthcare Philippine...Australia;China;Denmark;Germany;Hong;Kong;India;Japan;Malaysia;Poland;Singapore;United;States
NCT06413823
Recruiting

Prevention and Treatment of Cardiovascular Disease

IRCCS Centro Neurolesi Bonino-...Italy
NCT06263452
Phase 4
Not yet recr...

Beta-Blocker Influences on Inflammatory and Neural Responses to Stress

University of North Carolina, ...United States of America
NCT05972850
Not yet recr...

Vivo Heart: Home-Based Virtual Exercise Program for Older Adults With Cardiovascular Disease

Wake Forest University Health ...United States of America
NCT05904639
Phase 1
Not yet recr...

Decoding Your Diet (DYD)

Morehouse School of MedicineUnited States of America
2022-003060-25
Ongoing

Open-label, multicenter, multinational, interventional Clinical Trial to assess Efficacy and Safety of the extemporaneous combination of Nebivolol and Ramipril in hypertensive patients - ARTEMISIA study

Menarini International Operati...
2021-003059-41
Ongoing

A randomized, double-blind, placebo-controlled, multicenter trial assessing the reduction of the rate of lipoprotein apheresis after treatment with pelacarsen (TQJ230) compared to placebo in patients with hyperlipoproteinemia(a) and established cardiovascular disease undergoing weekly lipoprotein apheresis in Germany

Novartis Pharma AG
NCT05361421
Phase 4
Recruiting

Effect of Intensive LDL-cholesterol Targeting for Elderly Patients With Cardiovascular Disease: I-OLD Trial

Yonsei UniversitySouth Korea
KCT0007029
Not Applicable
Completed

Untitled Trial

Korea UniversitySouth Korea
NCT05214989
Not yet recr...

Tailored Interventions to Increase Cardiac Rehabilitation Enrollment

VA Office of Research and Deve...United States of America
NCT04927429
Recruiting

Technical Development of Cardiovascular Magnetic Resonance Imaging

National Heart, Lung, and Bloo...United States of America
jRCT2031200367
Completed

Untitled Trial

Amgen K.K.Australia;Canada;Iceland;United States of America;Denmark;Netherlands
NCT04749927
Recruiting

Deep Learning of Retinal Photographs and Atherosclerotic Cardiovascular Disease

Yonsei UniversitySouth Korea
NCT04717336
Early Phase 1
Recruiting

Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African Americans Study (GENE-FORECAST): Sodium Intervention Trial (SIT)

National Human Genome Research...United States of America
NCT04686591
Phase 1
Completed

Absolute Bioavailability and ADME Study of [14C]AZD9977 in Healthy Male Subjects

AstraZenecaUnited Kingdom
ChiCTR2000039640
Early Phase 1
Recruiting

Untitled Trial

Beijing Tsinghua Changgung Hos...China
NCT04611932
Phase 1
Not yet recr...

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-333 Low Dose in Healthy Volunteers

Chong Kun Dang PharmaceuticalSouth Korea
NCT04588727
Phase 1
Recruiting

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AZD3366 in Healthy Subjects, Japanese and Chinese Subjects

AstraZenecaUnited States of America
NCT04492709
Phase 1
Completed

A Study to Assess the Effect of Multiple Doses of AZD5718 on Pharmacokinetics of Oral Midazolam in Healthy Subjects

AstraZenecaUnited Kingdom
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
About Cardiovascular Disease Research

Pure Global AI provides free access to 357 clinical trials studying Cardiovascular Disease, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Penn State University, AstraZeneca, National Heart, Lung, and Blood Institute (NHLBI), among others.

Quick Facts
Total Trials357
Countries10+
Sponsors10+
Recruiting16